| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K61166597 |
| PharmacoGx | BRD-K61166597 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GABPA | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | DRAXIN | CTRPv2 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | TUBB6 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | CYP20A1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | ZSWIM8 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | CCDC28A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | ZCCHC6 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | DHX15 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | PDCD11 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | C16orf92 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
